Driving Innovation from Ireland

Sponsored by Gilead Sciences Ltd.

David Cadogan Vice President, Manufacturing Operations, Ireland, Gilead Sciences

At Gilead, we are driven by our purpose of making the world a healthier place. This means delivering innovative therapies that offer new hope for patients, which our Irish operations have been a central part of for the past 25 years.

Firstly, from our manufacturing site at Carrigtwohill in Co. Cork, but now supported by three more offices in Cork and Dublin, including our Global Paediatric Drug Development Centre of Excellence, which is at the forefront of our global development plans to improve the health of children.

Our ambitions have led us to a cure for hepatitis C and to transforming the treatment and prevention of HIV. These drugs, and many others, are manufactured here in Ireland – but, the innovation does not stop there. At Gilead, we want to find a cure for HIV and we are advancing options for long-acting treatment and prevention. We have also built an oncology portfolio that includes some of the most promising approaches in cancer treatment today, such as CAR-T cell therapy.

Our Irish operations act as a global hub of expertise, from paediatric clinical development through to manufacturing and commercialisation, as well as providing world-class financial and legal services to international markets.

Together, we ensure patients in Ireland and around the world have the treatment they need when they need it. Globally, we intend to deliver ten transformative medicines by 2030.

Ireland has been the ideal place for Gilead to expand its footprint in Europe with a supportive business environment, a world class, talented workforce, and an attractive corporate tax regime. With the move to a global minimum tax rate, the challenge facing Ireland is to ensure that it remains a vibrant and welcoming location for innovative, ambitious companies like Gilead to remain and grow.

Together, we ensure patients in Ireland and around the world have the treatment they need when they need it.

 
 
 
Previous
Previous

Global Digitalisation and the Impact on MedTech and Pharmaceutical Industries

Next
Next

At John Paul Construction, we’re proud to be part of the ongoing story of Foreign Direct Investment (FDI) in Ireland